C4 Therapeutics
CCCC
CCCC
106 hedge funds and large institutions have $476M invested in C4 Therapeutics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 25 closing their positions.
Holders
106
Holders Change
+14
Holders Change %
+15.22%
% of All Funds
1.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
39
Increased
29
Reduced
27
Closed
25
Calls
$6.88M
Puts
$4.6M
Net Calls
+$2.28M
Net Calls Change
+$1.29M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$58.4M |
| 2 |
SCM
2
Silverarc Capital Management
Boston,
Massachusetts
|
$11.7M |
| 3 |
3
Two Sigma Advisers
New York
|
$10.7M |
| 4 |
4
Two Sigma Investments
New York
|
$9.57M |
| 5 |
5
Goldman Sachs
New York
|
$10.5M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SC
126
Shay Capital
New York
| – | – | -10,000 | Closed |
|
|
FIA
127
FNY Investment Advisers
New York
| – | – | -8,800 | Closed |
|
|
HT
128
Headlands Technologies
Chicago,
Illinois
| – | – | -6,880 | Closed |
|
|
PAS
129
Point72 Asia (Singapore)
Singapore
| – | – | -3,928 | Closed |
|
|
FBC
130
Fairfield, Bush & Co
Darien,
Connecticut
| – | – | -200 | Closed |
|
|
CFGS
131
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
132
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CMP
133
Coston McIsaac & Partners
Bar Harbor,
Maine
| $0 | 23 | +4 | +21% |
|